With Edwards Lifesciences getting a key earnings report out of the way, the uncertainties hanging over EW stock has cleared for the bulls.

While UnitedHealth has struggled following a mixed earnings report, the smart money is relatively calm about the downside ...

Surgery was found to be slightly more cost-effective than radiotherapy for treating esophageal squamous cell carcinoma (ESCC) in China, according to a study published January 30 in Springer Nature.

While snakes and ladders is purely a game of chance, there is a way to add some strategy, says mathematician Peter Rowlett ...

A new study published in the Journal of American Medical Association showed that active surveillance may be appropriate for ...

Modeling study supports an FDA-approved product over off-label amitriptyline ...

Bismuth quadruple therapy (BQT) is the most cost-effective first-line therapy for treating Helicobacter pylori infection, from a United States (US) health care payer perspective. These findings were ...

Investigators reviewed data from the SANO trial to assess long-term comparative effectiveness of active surveillance vs standard esophagectomy in patients with complete clinical response following ...

At the core, information is only truly transmitted when the person receiving the intelligence enjoys a change in posterior ...

Avis Budget Group (CAR) isn’t exactly a confidence-inspiring name right now, with CAR stock losing roughly 22% in the past ...

Duloxetine 120 mg offers the greatest economic value for treating moderate-to-severe fibromyalgia, followed by pregabalin 450 ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...